Literature DB >> 15848126

Prolonged exposure to NT-3 attenuates cholinergic nerve-mediated contractions in cultured murine airways.

Ofir Bachar1, Mikael Adner, Rolf Uddman, Lars-Olaf Cardell.   

Abstract

Chronic airway inflammation may induce subsequent airway hyper-responsiveness (AHR) including pathological alteration of neural activity. Asthmatic airways contain elevated levels of neurotrophin-3 (NT-3) and brain-derived neurotrophic factor (BDNF) albeit, their effect on neural activity is unclear. This study evaluates the effects of NT-3 and BDNF on nerve mediated airway contractions in vitro. Tracheal segments from BALB/c J mice were cultured for 4 days with NT-3 or BDNF. Responsiveness to electric field stimulation (EFS) was evaluated in organ-bath and innervation patterns were examined by quantitative immunohistochemistry. In cultured segments the EFS-induced contractions were inhibited by tetrodotoxin or atropine. NT-3 reduced the EFS contractions in a concentration-dependent manner whereas BDNF had no effect. The amount of nerve fibers, found in conjunction with the tracheal smooth muscle, was similar in NT-3 treated and control segments. In conclusion, NT-3 attenuates cholinergic nerve-mediated contractions of airway in vitro. Considering the elevated levels of NT-3 found in asthmatic airways, the findings imply a protective role of NT-3 in AHR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848126     DOI: 10.1016/j.resp.2005.01.010

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  2 in total

1.  Neurotransmitters in airway parasympathetic neurons altered by neurotrophin-3 and repeated allergen challenge.

Authors:  Jenny Pan; Holly K Rhode; Bradley J Undem; Allen C Myers
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-09       Impact factor: 6.914

2.  Neurally mediated airway constriction in human and other species: a comparative study using precision-cut lung slices (PCLS).

Authors:  Marco Schlepütz; Annette D Rieg; Sophie Seehase; Jan Spillner; Alberto Perez-Bouza; Till Braunschweig; Thomas Schroeder; Marc Bernau; Verena Lambermont; Christina Schlumbohm; Katherina Sewald; Rüdiger Autschbach; Armin Braun; Boris W Kramer; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.